These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 6973392

  • 21. Macrophages as effector cells of protective immunity in murine schistosomiasis. II. Killing of newly transformed schistosomula in vitro by macrophages activated as a consequence of Schistosoma mansoni infection.
    James SL, Sher A, Lazdins JK, Meltzer MS.
    J Immunol; 1982 Apr; 128(4):1535-40. PubMed ID: 7061842
    [Abstract] [Full Text] [Related]

  • 22. Human alveolar macrophage FcR-mediated cytotoxicity. Heteroantibody- versus conventional antibody-mediated target cell lysis.
    Levy PC, Looney RJ, Shen L, Graziano RF, Fanger MW, Roberts NJ, Ryan DH, Utell MJ.
    J Immunol; 1990 May 15; 144(10):3693-700. PubMed ID: 2332629
    [Abstract] [Full Text] [Related]

  • 23. Tumor-associated macrophages of mouse mammary tumors. I. Differential cytotoxicity of macrophages from metastatic and nonmetastatic tumors.
    Loveless SE, Heppner GH.
    J Immunol; 1983 Oct 15; 131(4):2074-8. PubMed ID: 6619548
    [Abstract] [Full Text] [Related]

  • 24. Macrophage-induced enhancement of endogenous tumor lysosome activity.
    Urban JL.
    Cancer Res; 1981 Jun 15; 41(6):2221-9. PubMed ID: 7237422
    [Abstract] [Full Text] [Related]

  • 25. Spontaneous tumor cell killing by human blood monocytes and human peritoneal macrophages: lack of alteration by endotoxin or quenchers of reactive oxygen species.
    Weinberg JB, Haney AF.
    J Natl Cancer Inst; 1983 Jun 15; 70(6):1005-10. PubMed ID: 6574267
    [Abstract] [Full Text] [Related]

  • 26. A novel rat monoclonal antibody reactive with murine tumoricidal Kupffer cells and activated peritoneal macrophages from BCG-infected mice.
    Someya A.
    Immunology; 1986 Apr 15; 57(4):605-10. PubMed ID: 2420709
    [Abstract] [Full Text] [Related]

  • 27. Multiple tumoricidal effector mechanisms induced by adriamycin.
    Salazar D, Cohen SA.
    Cancer Res; 1984 Jun 15; 44(6):2561-6. PubMed ID: 6327018
    [Abstract] [Full Text] [Related]

  • 28. M2 macrophages phagocytose rituximab-opsonized leukemic targets more efficiently than m1 cells in vitro.
    Leidi M, Gotti E, Bologna L, Miranda E, Rimoldi M, Sica A, Roncalli M, Palumbo GA, Introna M, Golay J.
    J Immunol; 2009 Apr 01; 182(7):4415-22. PubMed ID: 19299742
    [Abstract] [Full Text] [Related]

  • 29. Ca2+-calmodulin regulates the induction and expression of macrophage cytotoxicity.
    Nguyen HK, Cain CA, Tompkins WA.
    J Biol Response Mod; 1987 Apr 01; 6(2):154-68. PubMed ID: 3585411
    [Abstract] [Full Text] [Related]

  • 30. Activation of macrophages for tumor cell cytotoxicity: identification of indomethacin sensitive and insensitive pathways.
    Drysdale BE, Shin HS.
    J Immunol; 1981 Aug 01; 127(2):760-5. PubMed ID: 6788847
    [Abstract] [Full Text] [Related]

  • 31. Corticosteroids block newly induced but not constitutive functions of macrophage cell lines: myeloid colony-stimulating activity production, latex phagocytosis, and antibody-dependent lysis of RBC and tumor targets.
    Ralph P, Ito M, Broxmeyer HE, Nakoinz I.
    J Immunol; 1978 Jul 01; 121(1):300-3. PubMed ID: 670703
    [Abstract] [Full Text] [Related]

  • 32. Differential sensitivity of tumor targets to liver macrophage-mediated cytotoxicity.
    Gardner CR, Wasserman AJ, Laskin DL.
    Cancer Res; 1987 Dec 15; 47(24 Pt 1):6686-91. PubMed ID: 3119198
    [Abstract] [Full Text] [Related]

  • 33. Antibody-dependent cellular cytotoxicity against tumor cells. I. Cultivated bone marrow-derived macrophages kill tumor targets.
    Lohmann-Matthes ML, Domzig W, Taskov H.
    Eur J Immunol; 1979 Apr 15; 9(4):261-6. PubMed ID: 467489
    [Abstract] [Full Text] [Related]

  • 34. Cytokine regulation of human monocyte differentiation in vitro: the tumor-cytotoxic phenotype induced by macrophage colony-stimulating factor is developmentally regulated by gamma-interferon.
    Munn DH, Armstrong E.
    Cancer Res; 1993 Jun 01; 53(11):2603-13. PubMed ID: 8495423
    [Abstract] [Full Text] [Related]

  • 35. Proteomic analysis of macrophages: a potential way to identify novel proteins associated with activation of macrophages for tumor cell killing.
    Zhang L, Zhu H, Lun Y, Yan D, Yu L, Du B, Zhu X.
    Cell Mol Immunol; 2007 Oct 01; 4(5):359-67. PubMed ID: 17976316
    [Abstract] [Full Text] [Related]

  • 36. Activation of mouse macrophages for tumor cell killing. I. Quantitative analysis of interactions between lymphokine and lipopolysaccharide.
    Pace JL, Russell SW.
    J Immunol; 1981 May 01; 126(5):1863-7. PubMed ID: 7217671
    [Abstract] [Full Text] [Related]

  • 37. Immunosensitization of prostate carcinoma cell lines for lymphocytes (CTL, TIL, LAK)-mediated apoptosis via the Fas-Fas-ligand pathway of cytotoxicity.
    Frost P, Ng CP, Belldegrun A, Bonavida B.
    Cell Immunol; 1997 Aug 25; 180(1):70-83. PubMed ID: 9316641
    [Abstract] [Full Text] [Related]

  • 38. Mechanisms of target recognition and destruction in macrophage-mediated tumor cytotoxicity.
    Adams DO, Johnson WJ, Marino PA.
    Fed Proc; 1982 Apr 25; 41(6):2212-21. PubMed ID: 6804274
    [Abstract] [Full Text] [Related]

  • 39. Fibronectin activates murine peritoneal macrophages for tumor cell destruction in the presence of IFN-gamma.
    Jun CD, Yoon HJ, Kim HM, Chung HT.
    Biochem Biophys Res Commun; 1995 Jan 26; 206(3):969-74. PubMed ID: 7832812
    [Abstract] [Full Text] [Related]

  • 40. Intracellular destruction of Leishmania tropica by macrophages activated with macrophage activating factor/interferon.
    Titus RG, Kelso A, Louis JA.
    Clin Exp Immunol; 1984 Jan 26; 55(1):157-65. PubMed ID: 6198115
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.